Executive Summary: A Month of Legislative Mobilization
February has proven to be a pivotal month for METAvivor, marked by the launch of the third annual GroundSwell Advocacy Event and significant shifts in the federal appropriations landscape. As the organization navigates the complexities of Washington, D.C., its mission remains clear: to secure increased funding for metastatic breast cancer (MBC) research, champion life-saving legislation, and improve the quality of data collection regarding patient outcomes. Through a blend of grassroots mobilization, coalition building, and strategic policy engagement, METAvivor continues to amplify the voices of patients, ensuring that the urgency of the MBC crisis is felt in the halls of Congress.
The Federal Funding and Policy Landscape: FY2026 and Beyond
Appropriations and the Legislative Machinery
The month began with a significant win for the cancer research community. On February 3, the signing of the Consolidated Appropriations Act of 2026 finalized a budget package that provides critical support for federal health agencies. Notably, the National Institutes of Health (NIH), the National Cancer Institute (NCI), and the Centers for Disease Control and Prevention’s (CDC) Division of Cancer Prevention and Control all received funding increases. Perhaps most crucially for the MBC community, the Department of Defense (DOD) Congressionally Directed Medical Research Program (CDMRP) for Breast Cancer saw a substantial increase, rising from $130 million in FY25 to $145 million in FY26.
This funding is the lifeblood of innovation, allowing for high-risk, high-reward research that traditional funding streams might overlook. However, the legislative process remains fraught with volatility. While the majority of the government is funded, the Department of Homeland Security (DHS) remains caught in a stalemate, resulting in a partial government shutdown of agency-related programs. While this does not directly impact cancer research funding, it serves as a stark reminder of the fragile nature of Congressional consensus.
Preparing for the FY2027 Cycle
Even as the ink dries on the FY26 budget, the machinery of the Capitol is already shifting toward the FY2027 appropriations cycle. Congressional offices are currently finalizing their internal processes for accepting funding requests, and the METAvivor advocacy team is acting in lockstep with national coalitions—specifically the AdHoc Group on Healthcare Funding and One Voice Against Cancer (OVAC). By aligning with these larger stakeholders, METAvivor ensures that the needs of MBC patients are represented in a unified, powerful, and scientifically backed request that maximizes the impact of every dollar allocated.
GroundSwell: Empowering the Grassroots
The centerpiece of METAvivor’s February strategy was the launch of the third annual GroundSwell Virtual Advocacy Event, which began on February 23 and is slated to continue through March 6.
Mobilization and Training
The efficacy of an advocate is only as strong as their preparation. To ensure that the over 100 advocates participating this year were fully equipped, METAvivor conducted rigorous training sessions. These included two comprehensive webinars for general advocates and a specialized session for State Captains—the volunteer leaders who coordinate state-level outreach.
The organization provided a "digital toolkit" that included:
- Legislative Fact Sheets: Essential for translating complex medical and policy issues into digestible talking points.
- Strategic Scripts: Templates for meeting invitations and follow-up emails to ensure professionalism and clarity.
- Staff Directories: A state-by-state breakdown of healthcare staff within House and Senate offices, ensuring that advocates are speaking to the right decision-makers.
By utilizing a post-meeting survey system, METAvivor is collecting real-time data on how offices are responding to the concerns of their constituents, allowing for targeted follow-up where it is needed most.
Legislative Priorities: The Fight for Care and Parity
METAvivor’s legislative agenda is centered on two key pieces of legislation that aim to remove the systemic barriers faced by MBC patients:
1. The Metastatic Breast Cancer Access to Care Act (H.R. 2048 / S. 3442)
This legislation is critical to ensuring that patients do not face unnecessary delays in accessing essential care. As of late February, H.R. 2048 has gained significant momentum, reaching 214 cosponsors (154 Democrats and 60 Republicans). The Senate companion bill, S. 3442, is also gaining traction, growing its base of support from three to five cosponsors in a single month. These figures represent a growing bipartisan recognition that current waiting periods for Social Security Disability Insurance (SSDI) and Medicare are detrimental to those with a terminal diagnosis.
2. The Cancer Drug Parity Act
The Cancer Drug Parity Act remains a top priority for the organization. With 26 cosponsors currently signed on in the House, the goal for the coming months is to secure a path forward for re-introduction in the Senate. METAvivor is currently finalizing its 2026 legislative priorities document, which will serve as the roadmap for all advocacy work throughout the remainder of the year.
Data Integrity: The SEER Strategy and Agency Engagement
A significant portion of METAvivor’s long-term policy strategy involves the National Cancer Institute’s Surveillance, Epidemiology, and End Results (SEER) program. The registry is the gold standard for tracking cancer data, yet it has historically struggled to capture the nuance of metastatic disease.
In February, METAvivor initiated a series of productive dialogues with the North American Association of Central Cancer Registries (NAACCR). The goal is to move beyond identification of the problem and toward a concrete policy ask regarding the modernization of cancer registries. Without accurate, granular data on metastatic incidence and survival, the medical community remains blind to the true scale of the epidemic. METAvivor’s work with the Alliance for Breast Cancer Policy aims to elevate these concerns, pushing for greater transparency and improved tracking mechanisms.
Technological Evolution: Modernizing Advocacy Infrastructure
Recognizing that the landscape of advocacy is shifting toward digital-first engagement, METAvivor’s Advocacy Committee is currently evaluating new infrastructure to better support its volunteers.
The team has been exploring the integration of Voter Voice, a sophisticated digital advocacy platform. The potential benefits include:
- Streamlined Communication: Automated tools that allow advocates to reach their representatives via email, social media, or phone with a single click.
- Data Maintenance: Better tracking of advocate engagement, allowing the organization to identify and mobilize "grasstops" supporters—individuals with personal connections to policymakers.
- System Integration: Ensuring that new software complements, rather than complicates, the existing internal databases used by METAvivor leadership.
This modernization effort is a direct response to the need for faster, more effective grassroots mobilization in an increasingly crowded political environment.
Looking Ahead: The Path to the Thriving Together Conference
As the organization transitions into the spring, the focus remains on the "Thriving Together: 2026 Conference on Metastatic Breast Cancer." This event will not only serve as a gathering for the community but as a strategic hub for advocacy. METAvivor intends to use the conference to bridge the gap between clinical research and policy action, ensuring that attendees leave with the tools to continue the fight at the local and national levels.
Summary of Upcoming Objectives:
- Post-GroundSwell Follow-up: Ensuring that the connections made during the virtual event are nurtured into long-term relationships with Congressional staff.
- FY27 Appropriations: Coordinating with coalition partners to secure continued funding increases for the NCI and DOD programs.
- Senate Advocacy: Driving the re-introduction and support for the Cancer Drug Parity Act in the upper chamber.
- SEER Strategy: Deepening technical discussions with registry experts to develop a clear, actionable policy proposal for better metastatic disease data collection.
In conclusion, February has been a month of intensive labor and strategic positioning for METAvivor. By balancing the immediate needs of federal budget cycles with the long-term goal of systemic policy reform, the organization continues to prove itself an indispensable force in the metastatic breast cancer community. As these initiatives move into the spring, the dedication of the GroundSwell advocates and the strategic acumen of the leadership team remain the primary engines of progress in the fight against this disease.
About the Author
